C Cachera
Overview
Explore the profile of C Cachera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kandoussi A, Hugue V, Cachera C, Hazzan M, Dracon M, TACQUET A, et al.
Nephron
. 1998 Sep;
80(2):183-7.
PMID: 9736817
Plasma lipoprotein (a) (LP(a)) concentrations are increased in patients with end-stage renal disease. Considering the influence of the apolipoprotein (a) (Apo(a)) polymorphism and the mode of dialysis in this prospective...
2.
Hugue V, Kandoussi M, Parra H, Dracon M, Fruchart J, TACQUET A, et al.
Nephrol Dial Transplant
. 1996 May;
11(5):825-9.
PMID: 8671902
Background: To examine the possible alteration in Lp(a) composition, protein and lipid contents of Lp(a) were determined in 10 haemodialysis patients (HD) matched with 10 controls (C) for apo(a) phenotypes....
3.
READE V, Mezdour H, Reade R, Kandoussi M, Dracon M, Fruchart J, et al.
Am J Nephrol
. 1996 Jan;
16(5):394-401.
PMID: 8886176
Abnormalities in cholesteryl ester transfers may play a role in the development of atherosclerosis observed in patients with end-stage renal failure treated by chronic hemodialysis. Net neutral-lipid transfers and cholesteryl...
4.
Kandoussi A, Hugue V, Parra H, Dracon M, Fruchart J, TACQUET A, et al.
Am J Nephrol
. 1996 Jan;
16(4):287-92.
PMID: 8739280
Whole plasma from 6 normolipidemic chronic renal failure (CRF) patients undergoing hemodialysis treatment was passed through the anti-apolipoprotein (Apo) AI immunosorbent column connected to the anti-Apo B immunoaffinity column. Apo...
5.
READE V, Tailleux A, Reade R, Harduin P, Cachera C, TACQUET A, et al.
Kidney Int
. 1993 Dec;
44(6):1360-5.
PMID: 7508006
Serum and isolated low-density lipoprotein (LDL) composition abnormalities were investigated in 20 hemodialyzed patients with chronic renal failure and 15 healthy normolipidemic subjects for comparison. LDL apolipoprotein B (apo B)...
6.
Kandoussi A, Cachera C, Pagniez D, Saile R, TACQUET A
Clin Chem
. 1993 Jan;
39(1):93-6.
PMID: 8419067
An enzyme-linked immunosorbent assay (ELISA) was developed for measuring beta 2-microglobulin (beta 2m) and albumin in continuous ambulatory peritoneal dialysis (CAPD) fluid. Plasma concentrations of beta 2m were twofold greater...
7.
Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart J, TACQUET A
Kidney Int
. 1992 Aug;
42(2):424-5.
PMID: 1405325
Plasma Lp(a) lipoprotein level was determined in chronic renal failure (CRF) patients, 24 before initiation of dialysis, 18 undergoing hemodialysis, and 24 on continuous ambulatory peritoneal dialysis (CAPD). Eighteen healthy...
8.
Kandoussi A, Cachera C, Reade R, Pagniez D, Fruchart J, TACQUET A
Nephrol Dial Transplant
. 1992 Jan;
7(10):1026-9.
PMID: 1331878
Plasma lipids and apolipoproteins were determined in 18 patients with chronic renal failure on haemodialysis (HD), 18 patients on continuous ambulatory peritoneal dialysis (CAPD), and 18 healthy controls. Significant differences...
9.
Saile R, Kandoussi A, DeVeaux M, Descamps J, Hachulla E, Cachera C
Clin Chem
. 1991 Oct;
37(10 Pt 1):1742-5.
PMID: 1914177
This enzyme-linked immunosorbent assay procedure for quantifying serum amyloid P (SAP) in human plasma makes use of affinity-purified polyclonal antibodies to SAP in a "sandwich"-type format. The procedure is sensitive,...
10.
Kandoussi A, Cachera C, Parsy D, Bard J, Fruchart J
J Immunoassay
. 1991 Jan;
12(3):305-23.
PMID: 1939663
A non competitive enzyme-linked immunosorbent assay (ELISA) for total apolipoprotein (apo) B, apo B with apo C-III (LpC-III:B), and apo B with apo E (LpE:B), was developed. Microtiter plates were...